Epi-on corneal crosslinking is advancing through innovations like supplemental oxygen, chemical oxygenation, and laser-assisted techniques. Kenneth Beckman, MD, discussed the latest advancements in ...

Aurion's AURN001, an allogeneic cell therapy for corneal edema, is advancing to phase 3 trials in 2025, having received FDA Breakthrough Therapy Designation. Arnaud Lacoste, PhD, is appointed CEO of ...

Pantheon Vision, a preclinical-stage medical device company developing bioengineered corneal implants to eliminate corneal blindness, today announced entering a collaboration agreement with ...

GENEVA, March 26, 2025--(BUSINESS WIRE)--Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a majority interest in ...

The drone successfully transported corneal tissue from Dr. Shroff’s Charity Eye Hospital (Sonipat centre) to the National Cancer Institute (NCI), AIIMS Jhajjar, and subsequently to AIIMS New ...

The prevalence and severity of refractive and corneal astigmatisms increased among children after the COVID-19 pandemic. Previous research has linked the pandemic to increases in myopia ...

Standards and guidelines for development co-operation with concrete examples of their implementation ...

Many patients who could benefit from corneal transplants are left without treatment due to the shortage of donor tissue. Artificial corneas could address this challenge. [iStockphoto] After years ...

In the procedure, an ophthalmologist (an eye specialist) cuts a flap in the clear tissue at the front of the eye, known as the cornea, using either a mechanical device or a laser. A hinge of tissue ...